All Stories

  1. In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder

    Article • Current Neuropharmacology, July 2025, Bentham Science Publishers

    Alireza Sharafshah, Professor kenneth Blum, Prof. Sergio Schmidt, Rajendra Badgaiyan, ROSSANO FIORELLI, Prof. Abdalla Bowirrat

  2. Waiting for the Eureka Moment in Psychiatry Research

    Article • Current Psychiatry Research and Reviews, February 2025, Bentham Science Publishers

    Rajendra Badgaiyan

  3. Using science to fix addiction forever - Reward Deficiency Syndrome Solutions

    Article • Current Pharmaceutical Biotechnology, January 2024, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, ELIZABETH GILLEY, Prof. Abdalla Bowirrat

  4. Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression

    Article • Current Psychopharmacologye, April 2022, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Marjorie Gondre-Lewis, Prof. Abdalla Bowirrat

  5. Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic

    Article • Current Psychopharmacologye, June 2021, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Prof. Abdalla Bowirrat

  6. Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise

    Article • Current Psychopharmacologye, June 2021, Bentham Science Publishers

    Bernard Downs, Professor kenneth Blum, Rajendra Badgaiyan, DR DEBASIS BAGCHI

  7. Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.

    Article • Current Psychopharmacologye, June 2020, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan

  8. Hypodopaminergia and “Precision Behavioral Management” (PBM): It is a Generational Family Affair

    Article • Current Pharmaceutical Biotechnology, May 2020, Bentham Science Publishers

    Marjorie Gondre-Lewis, Professor kenneth Blum, Rajendra Badgaiyan, Bernard Downs

  9. The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    Rajendra Badgaiyan, Professor kenneth Blum, Professor Zsolt Demetrovics

  10. Buprenorphine and Naloxone Combinations and Dopamine

    Article • Current Psychopharmacologye, January 2018, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Lyle Fried